- Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases BioSpace
- Alterity Therapeutics stock more than doubles on massive volume after new patent announcement MarketWatch
- Alterity Therapeutics nabs US patent for compounds for neurodegenerative disorders (NASDAQ:ATHE) Seeking Alpha
- Alterity Therapeutics collars US patent for next generation compounds Small Caps
- Alterity Therapeutics (ASX:ATH) receives U.S. patent for neurodegenerative diseases The Market Herald
- View Full Coverage on Google News
